US House passes, sends to Senate, $8.3 bln bill to battle coronavirus
The US House of Representatives on Wednesday overwhelmingly approved an $8.3 billion bill to combat
GSK ends development of Ebola vaccine, hands work to U.S. institute
British drugmaker GlaxoSmithKline is giving up its work on developing three potential vaccines